GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Embla Medical hf (OCSE:EMBLA) » Definitions » Beneish M-Score

Embla Medical hf (OCSE:EMBLA) Beneish M-Score : -2.43 (As of May. 12, 2024)


View and export this data going back to 2009. Start your Free Trial

What is Embla Medical hf Beneish M-Score?

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -2.43 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for Embla Medical hf's Beneish M-Score or its related term are showing as below:

OCSE:EMBLA' s Beneish M-Score Range Over the Past 10 Years
Min: -3.16   Med: -2.49   Max: -2.31
Current: -2.43

During the past 13 years, the highest Beneish M-Score of Embla Medical hf was -2.31. The lowest was -3.16. And the median was -2.49.


Embla Medical hf Beneish M-Score Historical Data

The historical data trend for Embla Medical hf's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Embla Medical hf Beneish M-Score Chart

Embla Medical hf Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Beneish M-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2.60 -2.94 -2.53 -2.40 -2.49

Embla Medical hf Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.40 -2.47 -2.50 -2.49 -2.43

Competitive Comparison of Embla Medical hf's Beneish M-Score

For the Medical Devices subindustry, Embla Medical hf's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Embla Medical hf's Beneish M-Score Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Embla Medical hf's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Embla Medical hf's Beneish M-Score falls into.



Embla Medical hf Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Embla Medical hf for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 1.0659+0.528 * 0.9977+0.404 * 1.0371+0.892 * 1.0646+0.115 * 1.0682
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 0.9669+4.679 * -0.023362-0.327 * 0.9717
=-2.43

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar24) TTM:Last Year (Mar23) TTM:
Total Receivables was kr894 Mil.
Revenue was 1370.945 + 1436.654 + 1348.067 + 1383.678 = kr5,539 Mil.
Gross Profit was 826.16 + 878.614 + 831.746 + 865.475 = kr3,402 Mil.
Total Current Assets was kr2,674 Mil.
Total Assets was kr10,599 Mil.
Property, Plant and Equipment(Net PPE) was kr1,330 Mil.
Depreciation, Depletion and Amortization(DDA) was kr352 Mil.
Selling, General, & Admin. Expense(SGA) was kr2,532 Mil.
Total Current Liabilities was kr1,589 Mil.
Long-Term Debt & Capital Lease Obligation was kr3,262 Mil.
Net Income was 56.662 + 129.82 + 97.087 + 108.452 = kr392 Mil.
Non Operating Income was 0 + 0 + 0 + 0 = kr0 Mil.
Cash Flow from Operations was 27.7 + 251.363 + 189.038 + 171.536 = kr640 Mil.
Total Receivables was kr788 Mil.
Revenue was 1259.822 + 1340.981 + 1328.261 + 1273.961 = kr5,203 Mil.
Gross Profit was 778.987 + 814.2 + 812.693 + 782.225 = kr3,188 Mil.
Total Current Assets was kr2,499 Mil.
Total Assets was kr9,292 Mil.
Property, Plant and Equipment(Net PPE) was kr1,218 Mil.
Depreciation, Depletion and Amortization(DDA) was kr350 Mil.
Selling, General, & Admin. Expense(SGA) was kr2,460 Mil.
Total Current Liabilities was kr1,443 Mil.
Long-Term Debt & Capital Lease Obligation was kr2,934 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(893.983 / 5539.344) / (787.761 / 5203.025)
=0.161388 / 0.151404
=1.0659

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(3188.105 / 5203.025) / (3401.995 / 5539.344)
=0.612741 / 0.614151
=0.9977

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (2674.348 + 1330.033) / 10599.296) / (1 - (2499.365 + 1217.9) / 9291.65)
=0.622203 / 0.599935
=1.0371

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=5539.344 / 5203.025
=1.0646

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(350.412 / (350.412 + 1217.9)) / (351.769 / (351.769 + 1330.033))
=0.223433 / 0.209162
=1.0682

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(2532.426 / 5539.344) / (2460.011 / 5203.025)
=0.457171 / 0.472804
=0.9669

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((3262.384 + 1589.004) / 10599.296) / ((2933.516 + 1443.04) / 9291.65)
=0.457709 / 0.47102
=0.9717

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(392.021 - 0 - 639.637) / 10599.296
=-0.023362

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Embla Medical hf has a M-score of -2.43 suggests that the company is unlikely to be a manipulator.


Embla Medical hf Beneish M-Score Related Terms

Thank you for viewing the detailed overview of Embla Medical hf's Beneish M-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Embla Medical hf (OCSE:EMBLA) Business Description

Traded in Other Exchanges
Address
Grjothals 5, Reykjavik, ISL
Ossur hf is engaged in the design, development, manufacture, and sale of prosthetics and bracing & support products. The company's products improve mobility through technologies in the field of braces, supports, prosthetic limbs, and compression therapy. Its segments are the Bracing & Supports and Prosthetics segment. The bracing & support products are used to support joints and other body parts for therapeutic and preventative purposes. The Prosthetics segment includes artificial limbs and related products for individuals born without limbs. Its geographical segments are the Americas; Europe, the Middle East & Africa (EMEA); and the Americas & Asia-Pacific (APAC), of which the Americas generate nearly half of the company's revenue.

Embla Medical hf (OCSE:EMBLA) Headlines

No Headlines